Cancer Council Victoria, Melbourne, Vic., Australia.
Deakin University, Burwood, Vic., Australia.
Eur J Haematol. 2017 Nov;99(5):423-430. doi: 10.1111/ejh.12941. Epub 2017 Oct 9.
To examine the influence of anxiety, depression and unmet supportive care needs on future quality of life (QoL) in multiple myeloma (MM) and diffuse large B-cell lymphoma (DLBCL) patients.
Multiple myeloma and DLBCL patients recruited through the population-based Victorian Cancer Registry. Data were collected through two telephone interviews: (T1) on average 7 months postdiagnosis, (T2) average 8 months later. QoL was examined at T2 using the Functional Assessment of Cancer Therapy (FACT-G) scale. The Hospital Anxiety and Depression Scale measured anxiety and depression, and the Supportive Care Needs Survey measured unmet needs at T1. Multivariate linear regression examined associations between QoL subscales (physical, emotional, social and functional well-being and overall QoL) and T1 anxiety, depression and unmet needs.
Except physical well-being, all other QoL subscales and overall QoL were significantly associated with T1 anxiety. All QoL subscales and overall QoL were significantly associated with T1 depression. Only patient care needs were associated with physical and social well-being and overall QoL.
Anxiety, depression and patient care unmet needs during treatment are associated with diminished physical and emotional well-being in the following months. Psychological distress and unmet supportive care needs experienced during treatment should be addressed to maximise future QoL.
探讨焦虑、抑郁和未满足的支持性护理需求对多发性骨髓瘤(MM)和弥漫性大 B 细胞淋巴瘤(DLBCL)患者未来生活质量(QoL)的影响。
通过基于人群的维多利亚癌症登记处招募多发性骨髓瘤和 DLBCL 患者。通过两次电话访谈收集数据:(T1)平均在诊断后 7 个月,(T2)平均 8 个月后。在 T2 使用癌症治疗功能评估量表(FACT-G)评估 QoL。医院焦虑和抑郁量表测量焦虑和抑郁,支持性护理需求调查测量 T1 时的未满足需求。多变量线性回归分析了 QoL 子量表(身体、情感、社会和功能健康以及总体 QoL)与 T1 焦虑、抑郁和未满足需求之间的关联。
除了身体状况外,所有其他 QoL 子量表和总体 QoL 均与 T1 焦虑显著相关。所有 QoL 子量表和总体 QoL 均与 T1 抑郁显著相关。只有患者护理需求与身体和社会健康以及总体 QoL 相关。
治疗期间的焦虑、抑郁和患者护理未满足需求与随后几个月身体和情绪健康状况恶化有关。治疗期间应解决心理困扰和未满足的支持性护理需求,以最大限度地提高未来的 QoL。